{"id":"https://openalex.org/W2016165863","doi":"https://doi.org/10.1111/j.1365-2133.2007.07814.x","title":"Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial","display_name":"Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial","publication_year":2007,"publication_date":"2007-03-28","ids":{"openalex":"https://openalex.org/W2016165863","doi":"https://doi.org/10.1111/j.1365-2133.2007.07814.x","mag":"2016165863","pmid":"https://pubmed.ncbi.nlm.nih.gov/17388924"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2133.2007.07814.x","doi":"https://doi.org/10.1111/j.1365-2133.2007.07814.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2133.2007.07814.x","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081924094","display_name":"Abdallah Khemis","orcid":"https://orcid.org/0000-0003-1329-5875","observed_orcids":["https://orcid.org/0000-0003-1329-5875"]},"institutions":[{"id":"https://openalex.org/I4210118460","display_name":"H\u00f4pital l'Archet","ror":"https://ror.org/02fsxgh46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018988418","https://openalex.org/I4210118460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Khemis","raw_affiliation_strings":["Dermatology Department, H\u00f4pital de L'Archet 2, Nice cedex 3, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Department, H\u00f4pital de L'Archet 2, Nice cedex 3, France","institution_ids":["https://openalex.org/I4210118460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048686233","display_name":"A. Kaiafa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118460","display_name":"H\u00f4pital l'Archet","ror":"https://ror.org/02fsxgh46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018988418","https://openalex.org/I4210118460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Kaiafa","raw_affiliation_strings":["Dermatology Department and CPCAD (Centre of Clinical Pharmacology Applied to Dermatology), H\u00f4pital de L'Archet 2, 06202 Nice cedex 3, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Department and CPCAD (Centre of Clinical Pharmacology Applied to Dermatology), H\u00f4pital de L'Archet 2, 06202 Nice cedex 3, France","institution_ids":["https://openalex.org/I4210118460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078060367","display_name":"Catherine Queille\u2010Roussel","orcid":"https://orcid.org/0000-0001-9443-3015","observed_orcids":["https://orcid.org/0000-0001-9443-3015"]},"institutions":[{"id":"https://openalex.org/I4210118460","display_name":"H\u00f4pital l'Archet","ror":"https://ror.org/02fsxgh46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018988418","https://openalex.org/I4210118460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Queille-Roussel","raw_affiliation_strings":["Dermatology Department and CPCAD (Centre of Clinical Pharmacology Applied to Dermatology), H\u00f4pital de L'Archet 2, 06202 Nice cedex 3, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Department and CPCAD (Centre of Clinical Pharmacology Applied to Dermatology), H\u00f4pital de L'Archet 2, 06202 Nice cedex 3, France","institution_ids":["https://openalex.org/I4210118460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091820328","display_name":"Luc Duteil","orcid":"https://orcid.org/0000-0002-9226-813X","observed_orcids":["https://orcid.org/0000-0002-9226-813X"]},"institutions":[{"id":"https://openalex.org/I4210118460","display_name":"H\u00f4pital l'Archet","ror":"https://ror.org/02fsxgh46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018988418","https://openalex.org/I4210118460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"L. Duteil","raw_affiliation_strings":["Dermatology Department and CPCAD (Centre of Clinical Pharmacology Applied to Dermatology), H\u00f4pital de L'Archet 2, 06202 Nice cedex 3, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Department and CPCAD (Centre of Clinical Pharmacology Applied to Dermatology), H\u00f4pital de L'Archet 2, 06202 Nice cedex 3, France","institution_ids":["https://openalex.org/I4210118460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111551156","display_name":"J.\u2010P. Ortonne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118460","display_name":"H\u00f4pital l'Archet","ror":"https://ror.org/02fsxgh46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018988418","https://openalex.org/I4210118460"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"J.P. Ortonne","raw_affiliation_strings":["Dermatology Department and CPCAD (Centre of Clinical Pharmacology Applied to Dermatology), H\u00f4pital de L'Archet 2, 06202 Nice cedex 3, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Department and CPCAD (Centre of Clinical Pharmacology Applied to Dermatology), H\u00f4pital de L'Archet 2, 06202 Nice cedex 3, France","institution_ids":["https://openalex.org/I4210118460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111551156"],"corresponding_institution_ids":["https://openalex.org/I4210118460"],"apc_list":{"value":3731,"currency":"GBP","value_usd":4920},"apc_paid":null,"fwci":5.4622,"has_fulltext":false,"cited_by_count":96,"citation_normalized_percentile":{"value":0.95759396,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"156","issue":"5","first_page":"997","last_page":"1004"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.7675999999046326,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.7675999999046326,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.23100000619888306,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melasma","display_name":"melasma","score":0.996999979019165},{"id":"https://openalex.org/keywords/hyperpigmentation","display_name":"hyperpigmentation","score":0.8980000019073486},{"id":"https://openalex.org/keywords/tyrosinase-inhibition","display_name":"tyrosinase inhibition","score":0.8700000047683716},{"id":"https://openalex.org/keywords/trp-1","display_name":"TRP-1","score":0.9139999747276306},{"id":"https://openalex.org/keywords/melanin-synthesis","display_name":"melanogenesis","score":0.9150000214576721},{"id":"https://openalex.org/keywords/skin-pigmentation","display_name":"skin pigmentation","score":0.421999990940094},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7630000114440918},{"id":"https://openalex.org/keywords/sunscreen","display_name":"sunscreen","score":0.5720000267028809},{"id":"https://openalex.org/keywords/women","display_name":"women","score":0.32600000500679016},{"id":"https://openalex.org/keywords/split-face-trial","display_name":"split-face trial","score":0.5540000200271606},{"id":"https://openalex.org/keywords/vehicle-control","display_name":"vehicle control","score":0.33399999141693115},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5730000138282776},{"id":"https://openalex.org/keywords/skin-lightening-products","display_name":"skin whitening products","score":0.3569999933242798}],"concepts":[{"id":"https://openalex.org/C2776677263","wikidata":"https://www.wikidata.org/wiki/Q305190","display_name":"Melasma","level":2,"score":0.9532009959220886},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8032511472702026},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.747400164604187},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5120930671691895},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37847524881362915}],"mesh":[{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007558","descriptor_name":"Italy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008548","descriptor_name":"Melanosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012118","descriptor_name":"Resorcinols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012880","descriptor_name":"Skin Pigmentation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2133.2007.07814.x","doi":"https://doi.org/10.1111/j.1365-2133.2007.07814.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2133.2007.07814.x","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},{"id":"pmid:17388924","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17388924","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of dermatology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W627610908","https://openalex.org/W1987569760","https://openalex.org/W2074923371","https://openalex.org/W2100781016","https://openalex.org/W2145135129","https://openalex.org/W2149456909","https://openalex.org/W2171596999","https://openalex.org/W2308018227","https://openalex.org/W2430631679","https://openalex.org/W4230145997"],"related_works":["https://openalex.org/W2146897012","https://openalex.org/W2062402299","https://openalex.org/W2280636911","https://openalex.org/W103703410","https://openalex.org/W2945989165","https://openalex.org/W4408498387","https://openalex.org/W4394012954","https://openalex.org/W2916881945","https://openalex.org/W3164620227","https://openalex.org/W7167509366"],"abstract_inverted_index":{"BACKGROUND:":[0],"Melasma":[1],"is":[2,13,43],"a":[3,26,101,200,280,300,323],"hyperpigmentation":[4],"disorder":[5],"predominantly":[6],"affecting":[7],"sun-exposed":[8],"areas":[9],"in":[10,29,57,123,283,370],"women,":[11],"which":[12,63],"often":[14],"refractory":[15],"to":[16,78,108,115,160,166,345,362,379],"treatment.":[17],"Most":[18],"commercially":[19],"available":[20],"treatments":[21],"incorporate":[22],"inhibitors":[23],"of":[24,40,67,82,92,120,162,209,222,228,290,308,353,376,384],"tyrosinase,":[25],"key":[27],"enzyme":[28],"melanin":[30],"production":[31],"within":[32],"the":[33,38,65,68,80,90,97,117,124,163,167,220,258,288,291,305,309,354],"melanocyte.":[34],"In":[35,128],"general,":[36],"however,":[37],"efficacy":[39,91,350,365],"these":[41],"therapies":[42],"somewhat":[44],"limited.":[45],"Recent":[46],"studies":[47],"have":[48,346,363],"identified":[49],"other":[50],"enzymes":[51],"that":[52,314],"play":[53],"an":[54,223],"important":[55],"role":[56],"melanogenesis,":[58],"including":[59],"tyrosinase-related":[60],"protein-1":[61],"(TRP-1),":[62],"catalyses":[64],"oxidation":[66],"melanogenetic":[69],"intermediate":[70],"5,6-dihydroxyindole-2-carbolylic":[71],"acid.":[72],"Rucinol":[73,335,358],"(4-n-butylresorcinol)":[74],"has":[75],"been":[76],"shown":[77,361],"inhibit":[79],"activity":[81],"both":[83],"tyrosinase":[84],"and":[85,111,114,193,204,207,212,238,249,319,340,342,381],"TRP-1.":[86],"OBJECTIVES:":[87],"To":[88],"assess":[89,116],"rucinol":[93,121,150,231,278,330],"serum":[94,122,151,336,359],"0.3%":[95,152],"vs.":[96],"corresponding":[98],"vehicle":[99,368],"as":[100],"treatment":[102,226],"for":[103,172,262,269],"melasma.":[104],"Secondary":[105],"objectives":[106],"were":[107,143,157,218],"evaluate":[109],"local":[110],"general":[112],"tolerability":[113,339],"skin":[118,210,264,271,315,385],"acceptability":[119,211,341],"target":[125],"population.":[126,356],"METHODS:":[127],"this":[129],"prospective,":[130],"single-centre,":[131],"double-blind,":[132],"randomized,":[133],"vehicle-controlled,":[134],"bilateral":[135],"(split-face)":[136],"comparative":[137],"trial,":[138],"32":[139],"women":[140],"with":[141,145,233,295,322,333,367],"melasma":[142,372],"provided":[144],"two":[146],"identical":[147],"tubes":[148],"containing":[149],"or":[153,348],"vehicle.":[154,296,334],"The":[155],"products":[156],"each":[158],"applied":[159,186],"one-half":[161],"face,":[164],"according":[165,378],"randomization":[168],"scheme,":[169],"twice":[170],"daily":[171],"12":[173,194,215,256],"weeks":[174,195,240],"(phase":[175,241],"1).":[176],"A":[177],"broad-spectrum":[178],"sunscreen":[179],"(sun":[180],"protection":[181],"factor":[182],"60)":[183],"was":[184,265,298,316,343,360],"also":[185,299],"daily.":[187],"Assessments":[188],"at":[189,235],"baseline,":[190],"4,":[191],"8":[192],"included":[196],"clinical":[197,259,380],"evaluations":[198],"by":[199,351],"dermatologist,":[201],"chromametry,":[202],"ultraviolet":[203],"standard":[205],"photography,":[206],"assessments":[208,383],"tolerability.":[213],"After":[214,255],"weeks,":[216,257],"patients":[217,245,251],"given":[219],"option":[221],"additional":[224],"3-month":[225],"period":[227],"open":[229],"full-face":[230],"treatment,":[232,377],"reviews":[234],"16,":[236],"20":[237],"24":[239],"2).":[242],"RESULTS:":[243],"Twenty-eight":[244],"completed":[246,252],"phase":[247,253,276],"1":[248],"26":[250],"2.":[254],"pigmentation":[260,285],"score":[261,286],"rucinol-treated":[263,306],"significantly":[266,317],"lower":[267],"than":[268],"vehicle-treated":[270],"(P":[272],"=":[273],"0.027).":[274],"During":[275],"2,":[277],"induced":[279],"significant":[281,302,364],"reduction":[282],"mean":[284],"on":[287,304],"half":[289],"face":[292],"previously":[293],"treated":[294],"There":[297],"further,":[301],"improvement":[303],"side":[307],"face.":[310],"Chromametry":[311],"measurements":[312],"showed":[313,337],"lighter":[318],"less":[320],"yellow,":[321],"strong":[324],"trend":[325],"towards":[326],"reduced":[327],"redness,":[328],"following":[329],"therapy":[331],"compared":[332,366],"good":[338,347],"considered":[344],"fair":[349],"78%":[352],"patient":[355],"CONCLUSIONS:":[357],"alone":[369],"improving":[371],"after":[373],"3":[374],"months":[375],"objective":[382],"colour.":[386]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}